New Treatment for Renal Cancer Extends Survival
Torisel (temsirolimus), an enzyme inhibitor, has received approval for advanced renal cell carcinoma (RCC) following a study of 626 patients.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.